Osaic Holdings’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed 7776
2022
Q2
$0 Buy
+100
New +$73 ﹤0.01% 7807
2021
Q3
Sell
-300
Closed -$2K 7451
2021
Q2
$2K Buy
300
+100
+50% +$843 ﹤0.01% 6786
2021
Q1
$2K Sell
200
-20
-9% -$207 ﹤0.01% 6562
2020
Q4
$2K Sell
220
-823
-79% -$10.2K ﹤0.01% 6139
2020
Q3
$16K Hold
1,043
﹤0.01% 5050
2020
Q2
$16K Buy
1,043
+830
+390% +$14.5K ﹤0.01% 4940
2020
Q1
$3K Buy
+213
New +$4.57K ﹤0.01% 5615

Other funds holding EPZM

Osaic Holdings's EPZM Position: Q3 2022 in Review

Osaic Holdings sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 100 shares.

Osaic Holdings first reported a position in EPZM in Q1 2020 and held it in 7 quarters. The position peaked at $16K in Q3 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Osaic Holdings reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 100 Epizyme, Inc shares in Q3 2022.
  • Osaic Holdings first reported a position in Epizyme, Inc in Q1 2020 and held it in 7 quarters.
  • Osaic Holdings's Epizyme, Inc position peaked at $16K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.